# OnCo record paper-mogamulizumab-relapsed-atll-phase-2-jco-2012 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-mogamulizumab-relapsed-atll-phase-2-jco-2012/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-mogamulizumab-relapsed-atll-phase-2-jco-2012" ;
  schema:name "Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study"@en ;
  schema:alternateName "Ishida 2012"@en, "KW-0761 phase 2"@en ;
  schema:description "The Japanese study in which the anti-CCR4 antibody mogamulizumab produced a response in half of people with relapsed adult T-cell leukaemia/lymphoma."@en ;
  schema:url <https://onco.cc/key-papers/paper-mogamulizumab-relapsed-atll-phase-2-jco-2012/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/JCO.2011.37.3472>, <https://pubmed.ncbi.nlm.nih.gov/22312108/>, <https://europepmc.org/article/MED/22312108> ;
  onco:tag "lymphoma-evidence-entities" ;
  schema:sameAs <https://doi.org/10.1200/JCO.2011.37.3472> ;
  schema:datePublished "2012"^^xsd:gYear ;
  schema:author "Ishida T, Joh T, Uike N, et al." ;
  onco:cancers <https://onco.cc/cancers/adult-t-cell-leukaemia-lymphoma/> ;
  onco:targets <https://onco.cc/targets/ccr4/> ;
  onco:drugs <https://onco.cc/drugs/mogamulizumab/> ;
  onco:trials <https://onco.cc/trials/mogamulizumab-atll-phase-2-japan/> .